Anne M Bowcock

Breast Cancer: Molecular Genetics, Pathogenesis, and Therapeutics - Contemporary Cancer Research Anne M Bowcock 1999 edition

Marc Notes: Includes bibliographical references and index. Review Quotes: "Extensive information about a multitude of topics associated with breast cancer genetics and possible causative factors in breast cancer progression is provided. This book also includes both a generalized overview of breast cancer therapeutics as well as the most current thoughts on experimental treatment ideas. The chapter, "Hereditary Breast Cancer Genes," is extremely well covered...the chapter on psychological issues surrounding genetic testing is particularly strong because of its use of case examples. The discussion of surgical and chemotherapeutic approaches is thorough and cohesive...this is an excellent resource for researchers in the field... This book stands out in that it provides a comprehensive approach to the relevant advances in breast cancer research as they apply to therapeutics, an approach that has been missing in the recent literature." -Doody's Health Sciences Book Review Journal ." . .successfully steers between the impossibility of a comprehensive book on all aspects of breast cancer and the undesirability of a quasi-random selection of isolated topics. The chapters are clearly written, succinct, and eminently readable for the physician as well as the molecular biologist. The book is well referenced and summarizes a wealth of data in a straight-forward and digestible manner. . . For the research scientists, epidemiologists, and clinician, this book will serve as an interesting and useful guide to the coming era."-The New England Journal of Medicine "The book has 25 chapters divided into 3 sections dealing with etiology and cancer genes, diagnosis, therapeutics and drug resistance, and environmental risk factors. Each chapter is densely packed with data. . . Lerman and Peshkin have written a very important chapter about the psychosocial aspects of genetic testing. Several case reports help make in the information relevant. . . The book will be extremely helpful to the graduate student and laboratory investigator who wants to havTable of Contents: Part I. Etiology: Genetic Changes Associated with Breast Cancer. The Estrogen Receptor and Breast Cancer, R. K. Hansen and S. A. W. Fuqua. Epidermal Growth Factor-Related Peptides and Their Cognate Receptors in Breast Cancer, Isabel Martinez-Lacaci, Caterina Bianco, Marta De Santis, and David S. Salomon. The Role of Fibroblast Growth Factors in Breast Cancer Pathogenesis and Progression, Francis G. Kern. Transforming Growth Factor-ss and Breast Cancer, Katri M. Koli and Carlos L. Arteaga. The Insulin-Like Growth Factor Network and Breast Cancer, Matthew J. Ellis. Molecular Alterations in Breast Cancer, Ivan Bergstein. Apoptosis and the Development of Breast Cancer, Priscilla A. Furth. WNT Genes and Breast Cancer, Ivan Bergstein and Anthony M. C. Brown. Hereditary Breast Cancer Genes, Lynda B. Bennett, Joel D. Taurog, and Anne M. Bowcock. Biological Functions of the BRCA1 and BRCA2 Proteins, Helen K. Chew, Andrew A. Farmer, and Wen-Hwa Lee. Psychosocial Issues in BRCA1/2 Testing, Caryn Lerman and Beth N. Peshkin. Part II. Biology of Tumor Progression: Breast Cancer Metastasis. Nm23, Breast Differentiation, and Cancer Metastasis, Patricia S. Steeg, Melanie T. Hartsough, and Susan e. Clare. Role of Integrins in the Development and Malignancy of the Breast, Edward C. Rosfjord and Robert B. Dickson. Matrix Metalloproteinases in the Pathogenesis of Breast Cancer, John R. MacDougall and Lynn M. Matrisian. The Urokinase Plasminogen Activation System in Breast Cancer, Anders N. Pedersen, Claus Holst-Hansen, Thomas L. Frandsen, Boye Schnack Nielsen, Ross W. Stephens, and Nils Brunner. Angiogenesis in Breast Cancer: Role in Biology, Tumor Progression, and Prognosis, Giampietro Gasparini. Part III. Therapeutics and Diagnostics: Diagnosis. Cytogenetic Approaches to Breast Cancer, Sverre Heim, Manuel R. Teixeira, and Nikos Pandis. Current and Future Directions in Surgical and Chemotherapeutic Approaches to Breast Cancer Treatment, George N. Peters. Breast Cancer Therapy UsingMonoclonal Antibodies Against Epidermal Growth Factor Receptor and HER-2, Zhen Fan and John Mendelsohn. Towards the Therapeutic Targeting of Matrix Metalloproteinases in Breast Cancer, Erik W. Thompson and George W. Sledge, Jr. MUC1 Mucin as a Tumor Antigen in Breast Cancer, Pawel Ciborowski, Elisabeth M. Hiltbold, Simon M. Barratt-Boyes, and Olivera J. Finn. Aromatase Inhibitors and the Role of Hormonal Therapy in Breast Cancer, Kendall E. Donaldson Herschler and Angela Brodie. Drug Resistance in Breast Cancer, Devchand Paul and Kenneth H. Cowan. Smoking as a Risk Factor for Breast Cancer, Christine B. Ambrosone and Peter G. Shields. The Estrogenicity of Selected Nutrients, Phytochemicals, Pesticides, and Pollutants: Their Potential Roles in Breast Cancer, Leena Hilakivi-Clarke, Bruce Trock, and Robert Clarke. Index."Publisher Marketing: A comprehensive state- of-the-art summary of breast cancer research and cytogenic

Contributor Bio:  Bowcock, Anne M Bowcock, University of Texas Southwestern Medical Center,, Dallas, TX.